|
Omic approach | Area of application | Ref. |
|
Genomics | Drug target identification Genetic disease markers Genome manipulation for target validation | [57ā59] |
|
Epigenomics | Study of epigenetic mechanisms of phytochemicals in the regulation of gene expression | [17] |
|
Metagenomics | Study of the relationship between the gut microflora and the pathophysiological state of the host and drug metabolism | [18] |
|
Toxicogenomics | Mechanism of toxicity (chronic, carcinogenic effect, and secondary effects of drugs) Biomarkers of toxicity and disease biomarkers Gene expression profiling of contaminants of herbal remedies for quality control Detection of toxic adulterants in herbal preparations Screening tests for prediction of toxicity of herbs in the drug development process | [14, 20, 21] |
|
Pharmacogenomics | Candidate genes with potential relevance in the efficacy and safety profile of TCMs Drug targets Identification of active compounds linking gene and disease information | [60] |
|
Herbonomics | Mechanism of action of herbal components Toxicity assessment of herbal remedies | [23, 24] |
|
Transcriptomics | Prediction of therapeutic potential and safety | [16] |
|
Proteomics | Therapeutic targets Exploration of pharmacological effect and mechanism of multitarget regulatory actions Quality control and toxicological profile of herbal remedies Disease diagnosis Biomarkers and monitoring of disease progression | [15, 16, 61, 62] |
|
Phosphoproteomics | Study of disease pathogenesis Disease biomarkers Drug targets | [14, 63] |
|
Glycoproteomics | Identification of aberrant proteins linked to pathophysiological processes Diagnosis biomarkers Mechanism of disease Drug targets | [14] |
|
Toxicoproteomics | Detection of biomarkers in response to xenobiotic exposure Prediction of toxic response to herbal components | [30] |
|
Chemoproteomics | Mechanism of disease Mechanism of action of compounds of interest | [14] |
|
Immunomics | Drug target Biomarker identification Study of immunomodulatory effect of herbs | [14, 62] |
|
Interactomics | Drug discovery Building interaction networks among interacting molecules | [14, 29] |
|
Metabolomics | Pharmacokinetics Pharmacodynamics Toxicology Disease diagnosis Molecular pathology Botanic identification Standardization of herbal remedies Quality control Elucidation of toxicological profile of herbal preparations | [64] |
|
Toxicometabolomics | Toxicity related biomarkers Molecular pathways involved in toxicological responses to botanicals | [14] |
|
Lipidomics | Mechanism of disease Drug target discovery Disease biomarkers | [14, 33, 45] |
|
Phytochemomics | Mechanism of action of herbal compounds Quality control of herbs Production of herb-based medicinal products Toxicity assessment | [34] |
|
Pharmacometabolomics | Study of phenotype signatures by mapping key pathways of the metabolic drug effects Pharmacology Drug discovery and drug development Personalized medicine | [63] |
|
Chinmedomics | Mechanism of action and metabolic profile of Chinese formulae Efficacy and safety of TCMs Disease biomarkers | [35ā37] |
|
Metallomics | Functional study of metal/metalloid-containing molecules and metabolites (i.e., genes, polysaccharides, and proteins) Mechanism of action of herbs Disease biomarkers Toxicological profile Quality control | [14, 45, 46, 65] |
|
Ionomics | Mechanism of disease Mechanism of action Disease biomarkers Toxicological profile Quality control | [50, 51] |
|
Phenomics | Disease biomarkers Biomarkers of survival Therapeutic targets | [66] |
|
Cytomics | Disease biomarkers Drug targets Target validation Personalized medicine Drug development Pharmacology Toxicology | [14, 54, 67] |
|